Drug intelligence / Profile preview

ibuprofen + propacetamol

Development stage
Preclinical
Lead developer
Boots
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Intravenous
01

Overview

Ibuprofen + propacetamol is a fixed-dose combination of two analgesic agents used for the management of acute pain, particularly in postoperative settings. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting cyclooxygenase (COX-1 and COX-2) enzymes, thereby reducing prostaglandin synthesis responsible for inflammation, pain, and fever. Propacetamol is a prodrug of paracetamol (acetaminophen), which acts primarily as an analgesic and antipyretic by inhibiting prostaglandin synthesis in the central nervous system. The combination leverages complementary mechanisms—ibuprofen’s peripheral anti-inflammatory action and propacetamol’s central analgesic effect—to provide superior pain relief compared to monotherapy with either agent alone. Clinical studies have shown that this combination reduces the need for opioid rescue medication after surgery in children without increasing adverse events[5]. It is especially considered when both anti-inflammatory and analgesic effects are desired or when monotherapy does not provide adequate pain control.

02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on ibuprofen + propacetamol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ibuprofen + propacetamol.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call